These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 116188)
1. Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages. Thomassen MJ; Boxerbaum B; Demko CA; Kuchenbrod PJ; Dearborn DG; Wood RE Pediatr Res; 1979 Sep; 13(9):1085-8. PubMed ID: 116188 [TBL] [Abstract][Full Text] [Related]
2. Ultrastructure and function of alveolar macrophages from cystic fibrosis patients. Thomassen MJ; Demko CA; Wood RE; Tandler B; Dearborn DG; Boxerbaum B; Kuchenbrod PJ Pediatr Res; 1980 May; 14(5):715-21. PubMed ID: 6770330 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum. Boxerbaum B; Kagumba A; Matthews LW Am Rev Respir Dis; 1973 Oct; 108(4):777-83. PubMed ID: 4200425 [No Abstract] [Full Text] [Related]
4. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264 [TBL] [Abstract][Full Text] [Related]
5. The role of antibody and complement in phagocytosis by rabbit alveolar macrophages. Murphey SA; Root RK; Schreiber AD J Infect Dis; 1979 Dec; 140(6):896-903. PubMed ID: 120385 [TBL] [Abstract][Full Text] [Related]
6. Letter: Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum. Biggar WD; Holmes B; Good RA Am Rev Respir Dis; 1974 Mar; 109(3):403. PubMed ID: 4205434 [No Abstract] [Full Text] [Related]
7. Phagocytosis of Pseudomonas aeruginosa by polymorphonuclear leukocytes and monocytes: effect of cystic fibrosis serum. Thomassen MJ; Demko CA; Wood RE; Sherman JM Infect Immun; 1982 Nov; 38(2):802-5. PubMed ID: 6815100 [TBL] [Abstract][Full Text] [Related]
8. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion. Hornick DB; Fick RB J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286 [TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay. Fick RB; Naegel GP; Matthay RA; Reynolds HY J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632 [TBL] [Abstract][Full Text] [Related]
10. Opsonic defect in patients with cystic fibrosis of the pancreas. Biggar WD; Holmes B; Good RA Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1716-9. PubMed ID: 5001942 [TBL] [Abstract][Full Text] [Related]
11. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay. LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181 [TBL] [Abstract][Full Text] [Related]
13. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa. Speert DP; Wong SY; Macdonald M; Sargeant R Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751 [TBL] [Abstract][Full Text] [Related]
14. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Berger M; Norvell TM; Tosi MF; Emancipator SN; Konstan MW; Schreiber JR Pediatr Res; 1994 Jan; 35(1):68-77. PubMed ID: 8134202 [TBL] [Abstract][Full Text] [Related]
15. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889 [TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases. Holby N; Olling S Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody? Fick RB; Reynolds HY Bull Eur Physiopathol Respir; 1983; 19(2):151-61. PubMed ID: 6871494 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185 [TBL] [Abstract][Full Text] [Related]
19. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591 [TBL] [Abstract][Full Text] [Related]
20. Function of human alveolar macrophages from normal volunteers and cigarette smokers: effect of cystic fibrosis serum. Thomassen MJ; Demko CA; Winnie GB; Sherman JM J Leukoc Biol; 1984 Apr; 35(4):345-55. PubMed ID: 6584525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]